摘要 |
Compounds having a structure of Formula I: or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, R3, R11a, R11b, R11c, R11d, X, n1, n2, and n3 are as defined herein, are provided. Uses of such compounds for modulating androgen receptor activity, imaging diagnostics in cancer and therapeutics, and methods for treatment of subjects in need thereof, including prostate cancer are also provided. |
申请人 |
BRITISH COLUMBIA CANCER AGENCY BRANCH;THE UNIVERSITY OF BRITISH COLUMBIA UNIVERSITY-INDUSTRY LIAISON OFFICE;SADAR, MARIANNE, DOROTHY;MAWJI, NASRIN, R.;BANUELOS, CARMEN, ADRIANA;ANDERSEN, RAYMOND, JOHN;FERNANDEZ, JAVIER, GARCIA;JIAN, KUNZHONG |
发明人 |
SADAR, MARIANNE, DOROTHY;MAWJI, NASRIN, R.;BANUELOS, CARMEN, ADRIANA;ANDERSEN, RAYMOND, JOHN;FERNANDEZ, JAVIER, GARCIA;JIAN, KUNZHONG |